Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults
[ Full article ]
In The News
AHRQ Evidence-Based Practice Update
Seeking Primary Care Practices to Participate in Improving Opioid Management
Get resources and guidance on how to implement effective team-based opioid management strategies in primary care by participating in the AHRQ-funded “Six Building Blocks” project. Selected practices will implement the Six Building Blocks toolkit to improve opioid prescribing and collect metrics to monitor progress. An anticipated 15 participating practices will each receive the resources and a $2,500 honorarium/practice to offset costs of data collection for the evaluation. The estimated start date for practices is late April 2019. Learn more here.
Protecting the Health and Safety of all Americans
Despite stringent safeguards, alarming stories continue to be reported about people, including some of our most vulnerable individuals, who have experienced harm in healthcare settings that is devastating to these patients and their families. These include cases of :
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
An Update to Three Recent MedWatch Safety Alert Recalls: on Angiotensin II Receptor Blocker Including Valsartan and Losartan.
- Losartan Potassium Tablets and Losartan Potassium/Hydrochlorothiazide Tablets by Torrent Pharmaceuticals Limited: Recall - Due to the Detection of Trace Amounts of N-Methylnitrosobutyric Acid Found in an Active Pharmaceutical Ingredient (API) (03/01/19)
- Amlodipine Valsartan Tablets and Valsartan Tablets by AurobindoPharma USA: Recall - Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity (03/01/19)
- Losartan Potassium Tablets by Camber Pharmaceuticals: Recall - Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino Butyric Acid (NMBA) Impurity Found in the API (02/28/19)
NIH study of brain energy patterns provides new insights into alcohol effects
Study could help understanding of how the brain uses energy in health and disease.
What's New at AHRQ
AHRQ Views—Blog: Step by Step, Improving Heart Health in America
Long periods of sedentary behavior may increase cardiovascular risk in older women
new study has found that the longer older women sit or lay down during the course of a day—and the longer the individual periods of uninterrupted sitting—the greater their risk of cardiovascular diseases such as heart disease and stroke. But...
Monthly buprenorphine injections effective for opioid use disorders
Study results on long-acting injection formulation now published.
Two decades of data reveal overall increase in pain, opioid use among U.S. adults
Researchers measured pain’s impact on normal work activities, people’s health status, and health care use.